Table of Content

1 Dendritic Cell Cancer Vaccine Market Overview
1.1 Product Overview and Scope of Dendritic Cell Cancer Vaccine
1.2 Dendritic Cell Cancer Vaccine Segment by Type
1.2.1 Global Dendritic Cell Cancer Vaccine Market Value Comparison by Type (2024-2034)
1.2.2 CreaVax
1.2.3 Sipuleucel-T (Provenge)
1.2.4 Others
1.3 Dendritic Cell Cancer Vaccine Segment by Application
1.3.1 Global Dendritic Cell Cancer Vaccine Market Value by Application: (2024-2034)
1.3.2 Pediatrics
1.3.3 Adults
1.4 Global Dendritic Cell Cancer Vaccine Market Size Estimates and Forecasts
1.4.1 Global Dendritic Cell Cancer Vaccine Revenue 2018-2034
1.4.2 Global Dendritic Cell Cancer Vaccine Sales 2018-2034
1.4.3 Global Dendritic Cell Cancer Vaccine Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 Dendritic Cell Cancer Vaccine Market Competition by Manufacturers
2.1 Global Dendritic Cell Cancer Vaccine Sales Market Share by Manufacturers (2018-2023)
2.2 Global Dendritic Cell Cancer Vaccine Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Dendritic Cell Cancer Vaccine Average Price by Manufacturers (2018-2023)
2.4 Global Dendritic Cell Cancer Vaccine Industry Ranking 2021 VS 2024 VS 2023
2.5 Global Key Manufacturers of Dendritic Cell Cancer Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Dendritic Cell Cancer Vaccine, Product Type & Application
2.7 Dendritic Cell Cancer Vaccine Market Competitive Situation and Trends
2.7.1 Dendritic Cell Cancer Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Dendritic Cell Cancer Vaccine Players Market Share by Revenue
2.7.3 Global Dendritic Cell Cancer Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Dendritic Cell Cancer Vaccine Retrospective Market Scenario by Region
3.1 Global Dendritic Cell Cancer Vaccine Market Size by Region: 2018 Versus 2024 Versus 2034
3.2 Global Dendritic Cell Cancer Vaccine Global Dendritic Cell Cancer Vaccine Sales by Region: 2018-2034
3.2.1 Global Dendritic Cell Cancer Vaccine Sales by Region: 2018-2023
3.2.2 Global Dendritic Cell Cancer Vaccine Sales by Region: 2024-2034
3.3 Global Dendritic Cell Cancer Vaccine Global Dendritic Cell Cancer Vaccine Revenue by Region: 2018-2034
3.3.1 Global Dendritic Cell Cancer Vaccine Revenue by Region: 2018-2023
3.3.2 Global Dendritic Cell Cancer Vaccine Revenue by Region: 2024-2034
3.4 North America Dendritic Cell Cancer Vaccine Market Facts & Figures by Country
3.4.1 North America Dendritic Cell Cancer Vaccine Market Size by Country: 2018 VS 2024 VS 2034
3.4.2 North America Dendritic Cell Cancer Vaccine Sales by Country (2018-2034)
3.4.3 North America Dendritic Cell Cancer Vaccine Revenue by Country (2018-2034)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Dendritic Cell Cancer Vaccine Market Facts & Figures by Country
3.5.1 Europe Dendritic Cell Cancer Vaccine Market Size by Country: 2018 VS 2024 VS 2034
3.5.2 Europe Dendritic Cell Cancer Vaccine Sales by Country (2018-2034)
3.5.3 Europe Dendritic Cell Cancer Vaccine Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Dendritic Cell Cancer Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Dendritic Cell Cancer Vaccine Market Size by Country: 2018 VS 2024 VS 2034
3.6.2 Asia Pacific Dendritic Cell Cancer Vaccine Sales by Country (2018-2034)
3.6.3 Asia Pacific Dendritic Cell Cancer Vaccine Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Dendritic Cell Cancer Vaccine Market Facts & Figures by Country
3.7.1 Latin America Dendritic Cell Cancer Vaccine Market Size by Country: 2018 VS 2024 VS 2034
3.7.2 Latin America Dendritic Cell Cancer Vaccine Sales by Country (2018-2034)
3.7.3 Latin America Dendritic Cell Cancer Vaccine Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Dendritic Cell Cancer Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Dendritic Cell Cancer Vaccine Market Size by Country: 2018 VS 2024 VS 2034
3.8.2 Middle East and Africa Dendritic Cell Cancer Vaccine Sales by Country (2018-2034)
3.8.3 Middle East and Africa Dendritic Cell Cancer Vaccine Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Dendritic Cell Cancer Vaccine Sales by Type (2018-2034)
4.1.1 Global Dendritic Cell Cancer Vaccine Sales by Type (2018-2023)
4.1.2 Global Dendritic Cell Cancer Vaccine Sales by Type (2024-2034)
4.1.3 Global Dendritic Cell Cancer Vaccine Sales Market Share by Type (2018-2034)
4.2 Global Dendritic Cell Cancer Vaccine Revenue by Type (2018-2034)
4.2.1 Global Dendritic Cell Cancer Vaccine Revenue by Type (2018-2023)
4.2.2 Global Dendritic Cell Cancer Vaccine Revenue by Type (2024-2034)
4.2.3 Global Dendritic Cell Cancer Vaccine Revenue Market Share by Type (2018-2034)
4.3 Global Dendritic Cell Cancer Vaccine Price by Type (2018-2034)
5 Segment by Application
5.1 Global Dendritic Cell Cancer Vaccine Sales by Application (2018-2034)
5.1.1 Global Dendritic Cell Cancer Vaccine Sales by Application (2018-2023)
5.1.2 Global Dendritic Cell Cancer Vaccine Sales by Application (2024-2034)
5.1.3 Global Dendritic Cell Cancer Vaccine Sales Market Share by Application (2018-2034)
5.2 Global Dendritic Cell Cancer Vaccine Revenue by Application (2018-2034)
5.2.1 Global Dendritic Cell Cancer Vaccine Revenue by Application (2018-2023)
5.2.2 Global Dendritic Cell Cancer Vaccine Revenue by Application (2024-2034)
5.2.3 Global Dendritic Cell Cancer Vaccine Revenue Market Share by Application (2018-2034)
5.3 Global Dendritic Cell Cancer Vaccine Price by Application (2018-2034)
6 Key Companies Profiled
6.1 Activarti
6.1.1 Activarti Corporation Information
6.1.2 Activarti Description and Business Overview
6.1.3 Activarti Dendritic Cell Cancer Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Activarti Dendritic Cell Cancer Vaccine Product Portfolio
6.1.5 Activarti Recent Developments/Updates
6.2 Argos Therapeutics
6.2.1 Argos Therapeutics Corporation Information
6.2.2 Argos Therapeutics Description and Business Overview
6.2.3 Argos Therapeutics Dendritic Cell Cancer Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Argos Therapeutics Dendritic Cell Cancer Vaccine Product Portfolio
6.2.5 Argos Therapeutics Recent Developments/Updates
6.3 SOTIO (Acquired by PPF Group)
6.3.1 SOTIO (Acquired by PPF Group) Corporation Information
6.3.2 SOTIO (Acquired by PPF Group) Description and Business Overview
6.3.3 SOTIO (Acquired by PPF Group) Dendritic Cell Cancer Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.3.4 SOTIO (Acquired by PPF Group) Dendritic Cell Cancer Vaccine Product Portfolio
6.3.5 SOTIO (Acquired by PPF Group) Recent Developments/Updates
6.4 Bellicum Pharmaceuticals
6.4.1 Bellicum Pharmaceuticals Corporation Information
6.4.2 Bellicum Pharmaceuticals Description and Business Overview
6.4.3 Bellicum Pharmaceuticals Dendritic Cell Cancer Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Bellicum Pharmaceuticals Dendritic Cell Cancer Vaccine Product Portfolio
6.4.5 Bellicum Pharmaceuticals Recent Developments/Updates
6.5 JW CreaGene
6.5.1 JW CreaGene Corporation Information
6.5.2 JW CreaGene Description and Business Overview
6.5.3 JW CreaGene Dendritic Cell Cancer Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.5.4 JW CreaGene Dendritic Cell Cancer Vaccine Product Portfolio
6.5.5 JW CreaGene Recent Developments/Updates
6.6 DanDrit
6.6.1 DanDrit Corporation Information
6.6.2 DanDrit Description and Business Overview
6.6.3 DanDrit Dendritic Cell Cancer Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.6.4 DanDrit Dendritic Cell Cancer Vaccine Product Portfolio
6.6.5 DanDrit Recent Developments/Updates
6.7 DCPrime
6.6.1 DCPrime Corporation Information
6.6.2 DCPrime Description and Business Overview
6.6.3 DCPrime Dendritic Cell Cancer Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 DCPrime Dendritic Cell Cancer Vaccine Product Portfolio
6.7.5 DCPrime Recent Developments/Updates
6.8 Elios Therapeutics
6.8.1 Elios Therapeutics Corporation Information
6.8.2 Elios Therapeutics Description and Business Overview
6.8.3 Elios Therapeutics Dendritic Cell Cancer Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Elios Therapeutics Dendritic Cell Cancer Vaccine Product Portfolio
6.8.5 Elios Therapeutics Recent Developments/Updates
6.9 ImmunoCellular Therapeutics
6.9.1 ImmunoCellular Therapeutics Corporation Information
6.9.2 ImmunoCellular Therapeutics Description and Business Overview
6.9.3 ImmunoCellular Therapeutics Dendritic Cell Cancer Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.9.4 ImmunoCellular Therapeutics Dendritic Cell Cancer Vaccine Product Portfolio
6.9.5 ImmunoCellular Therapeutics Recent Developments/Updates
6.10 Kiromic
6.10.1 Kiromic Corporation Information
6.10.2 Kiromic Description and Business Overview
6.10.3 Kiromic Dendritic Cell Cancer Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Kiromic Dendritic Cell Cancer Vaccine Product Portfolio
6.10.5 Kiromic Recent Developments/Updates
6.11 Medigene
6.11.1 Medigene Corporation Information
6.11.2 Medigene Dendritic Cell Cancer Vaccine Description and Business Overview
6.11.3 Medigene Dendritic Cell Cancer Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Medigene Dendritic Cell Cancer Vaccine Product Portfolio
6.11.5 Medigene Recent Developments/Updates
6.12 Merck
6.12.1 Merck Corporation Information
6.12.2 Merck Dendritic Cell Cancer Vaccine Description and Business Overview
6.12.3 Merck Dendritic Cell Cancer Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Merck Dendritic Cell Cancer Vaccine Product Portfolio
6.12.5 Merck Recent Developments/Updates
6.13 Northwest Biotherapeutics
6.13.1 Northwest Biotherapeutics Corporation Information
6.13.2 Northwest Biotherapeutics Dendritic Cell Cancer Vaccine Description and Business Overview
6.13.3 Northwest Biotherapeutics Dendritic Cell Cancer Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Northwest Biotherapeutics Dendritic Cell Cancer Vaccine Product Portfolio
6.13.5 Northwest Biotherapeutics Recent Developments/Updates
6.14 Immutep Limited
6.14.1 Immutep Limited Corporation Information
6.14.2 Immutep Limited Dendritic Cell Cancer Vaccine Description and Business Overview
6.14.3 Immutep Limited Dendritic Cell Cancer Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Immutep Limited Dendritic Cell Cancer Vaccine Product Portfolio
6.14.5 Immutep Limited Recent Developments/Updates
6.15 Dendreon Corporation
6.15.1 Dendreon Corporation Corporation Information
6.15.2 Dendreon Corporation Dendritic Cell Cancer Vaccine Description and Business Overview
6.15.3 Dendreon Corporation Dendritic Cell Cancer Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Dendreon Corporation Dendritic Cell Cancer Vaccine Product Portfolio
6.15.5 Dendreon Corporation Recent Developments/Updates
6.16 Oncobiomed
6.16.1 Oncobiomed Corporation Information
6.16.2 Oncobiomed Dendritic Cell Cancer Vaccine Description and Business Overview
6.16.3 Oncobiomed Dendritic Cell Cancer Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Oncobiomed Dendritic Cell Cancer Vaccine Product Portfolio
6.16.5 Oncobiomed Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Dendritic Cell Cancer Vaccine Industry Chain Analysis
7.2 Dendritic Cell Cancer Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Dendritic Cell Cancer Vaccine Production Mode & Process
7.4 Dendritic Cell Cancer Vaccine Sales and Marketing
7.4.1 Dendritic Cell Cancer Vaccine Sales Channels
7.4.2 Dendritic Cell Cancer Vaccine Distributors
7.5 Dendritic Cell Cancer Vaccine Customers
8 Dendritic Cell Cancer Vaccine Market Dynamics
8.1 Dendritic Cell Cancer Vaccine Industry Trends
8.2 Dendritic Cell Cancer Vaccine Market Drivers
8.3 Dendritic Cell Cancer Vaccine Market Challenges
8.4 Dendritic Cell Cancer Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Dendritic Cell Cancer Vaccine Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Dendritic Cell Cancer Vaccine Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Dendritic Cell Cancer Vaccine Market Competitive Situation by Manufacturers in 2024
Table 4. Global Dendritic Cell Cancer Vaccine Sales (Units) of Key Manufacturers (2018-2023)
Table 5. Global Dendritic Cell Cancer Vaccine Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Dendritic Cell Cancer Vaccine Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Dendritic Cell Cancer Vaccine Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Dendritic Cell Cancer Vaccine Average Price (USD/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Dendritic Cell Cancer Vaccine, Industry Ranking, 2021 VS 2024 VS 2023
Table 10. Global Key Manufacturers of Dendritic Cell Cancer Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Dendritic Cell Cancer Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Dendritic Cell Cancer Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Dendritic Cell Cancer Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dendritic Cell Cancer Vaccine as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Dendritic Cell Cancer Vaccine Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 17. Global Dendritic Cell Cancer Vaccine Sales by Region (2018-2023) & (Units)
Table 18. Global Dendritic Cell Cancer Vaccine Sales Market Share by Region (2018-2023)
Table 19. Global Dendritic Cell Cancer Vaccine Sales by Region (2024-2034) & (Units)
Table 20. Global Dendritic Cell Cancer Vaccine Sales Market Share by Region (2024-2034)
Table 21. Global Dendritic Cell Cancer Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Dendritic Cell Cancer Vaccine Revenue Market Share by Region (2018-2023)
Table 23. Global Dendritic Cell Cancer Vaccine Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Dendritic Cell Cancer Vaccine Revenue Market Share by Region (2024-2034)
Table 25. North America Dendritic Cell Cancer Vaccine Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 26. North America Dendritic Cell Cancer Vaccine Sales by Country (2018-2023) & (Units)
Table 27. North America Dendritic Cell Cancer Vaccine Sales by Country (2024-2034) & (Units)
Table 28. North America Dendritic Cell Cancer Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Dendritic Cell Cancer Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Dendritic Cell Cancer Vaccine Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 31. Europe Dendritic Cell Cancer Vaccine Sales by Country (2018-2023) & (Units)
Table 32. Europe Dendritic Cell Cancer Vaccine Sales by Country (2024-2034) & (Units)
Table 33. Europe Dendritic Cell Cancer Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Dendritic Cell Cancer Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Dendritic Cell Cancer Vaccine Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 36. Asia Pacific Dendritic Cell Cancer Vaccine Sales by Region (2018-2023) & (Units)
Table 37. Asia Pacific Dendritic Cell Cancer Vaccine Sales by Region (2024-2034) & (Units)
Table 38. Asia Pacific Dendritic Cell Cancer Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Dendritic Cell Cancer Vaccine Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Dendritic Cell Cancer Vaccine Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 41. Latin America Dendritic Cell Cancer Vaccine Sales by Country (2018-2023) & (Units)
Table 42. Latin America Dendritic Cell Cancer Vaccine Sales by Country (2024-2034) & (Units)
Table 43. Latin America Dendritic Cell Cancer Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Dendritic Cell Cancer Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Dendritic Cell Cancer Vaccine Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 46. Middle East & Africa Dendritic Cell Cancer Vaccine Sales by Country (2018-2023) & (Units)
Table 47. Middle East & Africa Dendritic Cell Cancer Vaccine Sales by Country (2024-2034) & (Units)
Table 48. Middle East & Africa Dendritic Cell Cancer Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Dendritic Cell Cancer Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Dendritic Cell Cancer Vaccine Sales (Units) by Type (2018-2023)
Table 51. Global Dendritic Cell Cancer Vaccine Sales (Units) by Type (2024-2034)
Table 52. Global Dendritic Cell Cancer Vaccine Sales Market Share by Type (2018-2023)
Table 53. Global Dendritic Cell Cancer Vaccine Sales Market Share by Type (2024-2034)
Table 54. Global Dendritic Cell Cancer Vaccine Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Dendritic Cell Cancer Vaccine Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Dendritic Cell Cancer Vaccine Revenue Market Share by Type (2018-2023)
Table 57. Global Dendritic Cell Cancer Vaccine Revenue Market Share by Type (2024-2034)
Table 58. Global Dendritic Cell Cancer Vaccine Price (USD/Unit) by Type (2018-2023)
Table 59. Global Dendritic Cell Cancer Vaccine Price (USD/Unit) by Type (2024-2034)
Table 60. Global Dendritic Cell Cancer Vaccine Sales (Units) by Application (2018-2023)
Table 61. Global Dendritic Cell Cancer Vaccine Sales (Units) by Application (2024-2034)
Table 62. Global Dendritic Cell Cancer Vaccine Sales Market Share by Application (2018-2023)
Table 63. Global Dendritic Cell Cancer Vaccine Sales Market Share by Application (2024-2034)
Table 64. Global Dendritic Cell Cancer Vaccine Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Dendritic Cell Cancer Vaccine Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Dendritic Cell Cancer Vaccine Revenue Market Share by Application (2018-2023)
Table 67. Global Dendritic Cell Cancer Vaccine Revenue Market Share by Application (2024-2034)
Table 68. Global Dendritic Cell Cancer Vaccine Price (USD/Unit) by Application (2018-2023)
Table 69. Global Dendritic Cell Cancer Vaccine Price (USD/Unit) by Application (2024-2034)
Table 70. Activarti Corporation Information
Table 71. Activarti Description and Business Overview
Table 72. Activarti Dendritic Cell Cancer Vaccine Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 73. Activarti Dendritic Cell Cancer Vaccine Product
Table 74. Activarti Recent Developments/Updates
Table 75. Argos Therapeutics Corporation Information
Table 76. Argos Therapeutics Description and Business Overview
Table 77. Argos Therapeutics Dendritic Cell Cancer Vaccine Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 78. Argos Therapeutics Dendritic Cell Cancer Vaccine Product
Table 79. Argos Therapeutics Recent Developments/Updates
Table 80. SOTIO (Acquired by PPF Group) Corporation Information
Table 81. SOTIO (Acquired by PPF Group) Description and Business Overview
Table 82. SOTIO (Acquired by PPF Group) Dendritic Cell Cancer Vaccine Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 83. SOTIO (Acquired by PPF Group) Dendritic Cell Cancer Vaccine Product
Table 84. SOTIO (Acquired by PPF Group) Recent Developments/Updates
Table 85. Bellicum Pharmaceuticals Corporation Information
Table 86. Bellicum Pharmaceuticals Description and Business Overview
Table 87. Bellicum Pharmaceuticals Dendritic Cell Cancer Vaccine Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 88. Bellicum Pharmaceuticals Dendritic Cell Cancer Vaccine Product
Table 89. Bellicum Pharmaceuticals Recent Developments/Updates
Table 90. JW CreaGene Corporation Information
Table 91. JW CreaGene Description and Business Overview
Table 92. JW CreaGene Dendritic Cell Cancer Vaccine Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 93. JW CreaGene Dendritic Cell Cancer Vaccine Product
Table 94. JW CreaGene Recent Developments/Updates
Table 95. DanDrit Corporation Information
Table 96. DanDrit Description and Business Overview
Table 97. DanDrit Dendritic Cell Cancer Vaccine Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 98. DanDrit Dendritic Cell Cancer Vaccine Product
Table 99. DanDrit Recent Developments/Updates
Table 100. DCPrime Corporation Information
Table 101. DCPrime Description and Business Overview
Table 102. DCPrime Dendritic Cell Cancer Vaccine Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 103. DCPrime Dendritic Cell Cancer Vaccine Product
Table 104. DCPrime Recent Developments/Updates
Table 105. Elios Therapeutics Corporation Information
Table 106. Elios Therapeutics Description and Business Overview
Table 107. Elios Therapeutics Dendritic Cell Cancer Vaccine Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 108. Elios Therapeutics Dendritic Cell Cancer Vaccine Product
Table 109. Elios Therapeutics Recent Developments/Updates
Table 110. ImmunoCellular Therapeutics Corporation Information
Table 111. ImmunoCellular Therapeutics Description and Business Overview
Table 112. ImmunoCellular Therapeutics Dendritic Cell Cancer Vaccine Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 113. ImmunoCellular Therapeutics Dendritic Cell Cancer Vaccine Product
Table 114. ImmunoCellular Therapeutics Recent Developments/Updates
Table 115. Kiromic Corporation Information
Table 116. Kiromic Description and Business Overview
Table 117. Kiromic Dendritic Cell Cancer Vaccine Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 118. Kiromic Dendritic Cell Cancer Vaccine Product
Table 119. Kiromic Recent Developments/Updates
Table 120. Medigene Corporation Information
Table 121. Medigene Description and Business Overview
Table 122. Medigene Dendritic Cell Cancer Vaccine Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 123. Medigene Dendritic Cell Cancer Vaccine Product
Table 124. Medigene Recent Developments/Updates
Table 125. Merck Corporation Information
Table 126. Merck Description and Business Overview
Table 127. Merck Dendritic Cell Cancer Vaccine Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 128. Merck Dendritic Cell Cancer Vaccine Product
Table 129. Merck Recent Developments/Updates
Table 130. Northwest Biotherapeutics Corporation Information
Table 131. Northwest Biotherapeutics Description and Business Overview
Table 132. Northwest Biotherapeutics Dendritic Cell Cancer Vaccine Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 133. Northwest Biotherapeutics Dendritic Cell Cancer Vaccine Product
Table 134. Northwest Biotherapeutics Recent Developments/Updates
Table 135. Immutep Limited Corporation Information
Table 136. Immutep Limited Description and Business Overview
Table 137. Immutep Limited Dendritic Cell Cancer Vaccine Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 138. Immutep Limited Dendritic Cell Cancer Vaccine Product
Table 139. Immutep Limited Recent Developments/Updates
Table 140. Dendreon Corporation Corporation Information
Table 141. Dendreon Corporation Description and Business Overview
Table 142. Dendreon Corporation Dendritic Cell Cancer Vaccine Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 143. Dendreon Corporation Dendritic Cell Cancer Vaccine Product
Table 144. Dendreon Corporation Recent Developments/Updates
Table 145. Oncobiomed Corporation Information
Table 146. Oncobiomed Description and Business Overview
Table 147. Oncobiomed Dendritic Cell Cancer Vaccine Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 148. Oncobiomed Dendritic Cell Cancer Vaccine Product
Table 149. Oncobiomed Recent Developments/Updates
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Dendritic Cell Cancer Vaccine Distributors List
Table 153. Dendritic Cell Cancer Vaccine Customers List
Table 154. Dendritic Cell Cancer Vaccine Market Trends
Table 155. Dendritic Cell Cancer Vaccine Market Drivers
Table 156. Dendritic Cell Cancer Vaccine Market Challenges
Table 157. Dendritic Cell Cancer Vaccine Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Dendritic Cell Cancer Vaccine
Figure 2. Global Dendritic Cell Cancer Vaccine Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Dendritic Cell Cancer Vaccine Market Share by Type in 2024 & 2034
Figure 4. CreaVax Product Picture
Figure 5. Sipuleucel-T (Provenge) Product Picture
Figure 6. Others Product Picture
Figure 7. Global Dendritic Cell Cancer Vaccine Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 8. Global Dendritic Cell Cancer Vaccine Market Share by Application in 2024 & 2034
Figure 9. Pediatrics
Figure 10. Adults
Figure 11. Global Dendritic Cell Cancer Vaccine Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 12. Global Dendritic Cell Cancer Vaccine Market Size (2018-2034) & (US$ Million)
Figure 13. Global Dendritic Cell Cancer Vaccine Sales (2018-2034) & (Units)
Figure 14. Global Dendritic Cell Cancer Vaccine Average Price (USD/Unit) & (2018-2034)
Figure 15. Dendritic Cell Cancer Vaccine Report Years Considered
Figure 16. Dendritic Cell Cancer Vaccine Sales Share by Manufacturers in 2024
Figure 17. Global Dendritic Cell Cancer Vaccine Revenue Share by Manufacturers in 2024
Figure 18. The Global 5 and 10 Largest Dendritic Cell Cancer Vaccine Players: Market Share by Revenue in 2024
Figure 19. Dendritic Cell Cancer Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2024
Figure 20. Global Dendritic Cell Cancer Vaccine Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Figure 21. North America Dendritic Cell Cancer Vaccine Sales Market Share by Country (2018-2034)
Figure 22. North America Dendritic Cell Cancer Vaccine Revenue Market Share by Country (2018-2034)
Figure 23. U.S. Dendritic Cell Cancer Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 24. Canada Dendritic Cell Cancer Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 25. Europe Dendritic Cell Cancer Vaccine Sales Market Share by Country (2018-2034)
Figure 26. Europe Dendritic Cell Cancer Vaccine Revenue Market Share by Country (2018-2034)
Figure 27. Germany Dendritic Cell Cancer Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 28. France Dendritic Cell Cancer Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 29. U.K. Dendritic Cell Cancer Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 30. Italy Dendritic Cell Cancer Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 31. Russia Dendritic Cell Cancer Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 32. Asia Pacific Dendritic Cell Cancer Vaccine Sales Market Share by Region (2018-2034)
Figure 33. Asia Pacific Dendritic Cell Cancer Vaccine Revenue Market Share by Region (2018-2034)
Figure 34. China Dendritic Cell Cancer Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 35. Japan Dendritic Cell Cancer Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 36. South Korea Dendritic Cell Cancer Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 37. India Dendritic Cell Cancer Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 38. Australia Dendritic Cell Cancer Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 39. Taiwan Dendritic Cell Cancer Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 40. Indonesia Dendritic Cell Cancer Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. Thailand Dendritic Cell Cancer Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 42. Malaysia Dendritic Cell Cancer Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 43. Philippines Dendritic Cell Cancer Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 44. Latin America Dendritic Cell Cancer Vaccine Sales Market Share by Country (2018-2034)
Figure 45. Latin America Dendritic Cell Cancer Vaccine Revenue Market Share by Country (2018-2034)
Figure 46. Mexico Dendritic Cell Cancer Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 47. Brazil Dendritic Cell Cancer Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 48. Argentina Dendritic Cell Cancer Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 49. Middle East & Africa Dendritic Cell Cancer Vaccine Sales Market Share by Country (2018-2034)
Figure 50. Middle East & Africa Dendritic Cell Cancer Vaccine Revenue Market Share by Country (2018-2034)
Figure 51. Turkey Dendritic Cell Cancer Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 52. Saudi Arabia Dendritic Cell Cancer Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 53. U.A.E Dendritic Cell Cancer Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 54. Global Sales Market Share of Dendritic Cell Cancer Vaccine by Type (2018-2034)
Figure 55. Global Revenue Market Share of Dendritic Cell Cancer Vaccine by Type (2018-2034)
Figure 56. Global Dendritic Cell Cancer Vaccine Price (USD/Unit) by Type (2018-2034)
Figure 57. Global Sales Market Share of Dendritic Cell Cancer Vaccine by Application (2018-2034)
Figure 58. Global Revenue Market Share of Dendritic Cell Cancer Vaccine by Application (2018-2034)
Figure 59. Global Dendritic Cell Cancer Vaccine Price (USD/Unit) by Application (2018-2034)
Figure 60. Dendritic Cell Cancer Vaccine Value Chain
Figure 61. Dendritic Cell Cancer Vaccine Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed